NEW YORK (GenomeWeb News) — Warnex last week said it will retain its lab-services business as an external review launched in April to study “various strategic options” for the unit has ended.
 
Warnex's board “has concluded that at the present time, the option which provides the most value for its shareholders is the continued operation of its laboratory-services business,” the company said in a statement.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The partially reinstated US travel ban leaves space for uncertainty for researchers, Nature News says.

Researchers find a number of traits differ by sex and could affect mouse model studies, according to Reuters.

Tweaking the skin microbiome could help address some skin conditions, the New York Times reports.

In PNAS this week: DNA methylation profiles of tumor tissue, gene dynamics in prokaryotes, and more.